Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 11 - 20 of 372
UroGen Pharma Ltd. et al v. Teva Pharmaceuticals, Inc. et al
as 1:2024cv00417
Plaintiff: UroGen Pharma Ltd. and UroGen Pharma Inc.
Defendant: Teva Pharmaceuticals, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Teva Pharmaceuticals International GmbH et al v. BendaRx USA Corp
as 1:2024cv00395
Plaintiff: Teva Pharmaceuticals International GmbH, Cephalon, LLC and Eagle Pharmaceuticals Inc.
Defendant: BendaRx USA Corp
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Hetero Labs Limited et al
as 1:2024cv00396
Plaintiff: Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant: Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer HealthCare LLC et al v. Aurobindo Pharma Ltd. et al
as 1:2024cv00399
Plaintiff: Bayer HealthCare LLC and Meda Pharmaceuticals Inc.
Defendant: Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Pfizer Inc. et al v. Zydus Lifesciences Ltd. et al
as 1:2024cv00316
Plaintiff: Pfizer Inc., Global Blood Therapeutics, Inc. and PF PRISM IMB B.V.
Defendant: Zydus Lifesciences Ltd., Zydus Worldwide DMCC and Zydus Pharmaceuticals (USA) Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AbbVie Inc. v. Hetero Labs Limited et al
as 1:2024cv00151
Plaintiff: AbbVie Inc.
Defendant: Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Advanced Accelerator Applications USA, Inc. et al v. Lantheus Medical Imaging, Inc. et al
as 1:2024cv00095
Plaintiff: Advanced Accelerator Applications USA, Inc. and Advanced Accelerator Applications SA
Defendant: Lantheus Medical Imaging, Inc., Lantheus Holdings, Inc., Point Biopharma USA Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation et al v. Novugen Oncology Sdn. Bhd. et al
as 1:2023cv01449
Plaintiff: Novartis Pharmaceuticals Corporation, Novartis Pharma AG and Japan Tobacco Inc.
Defendant: Novugen Oncology Sdn. Bhd., Novugen Pharma (USA) LLC and Makro Technologies, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Bayer Pharma AG et al v. Aurobindo Pharma Limited et al
as 1:2023cv01372
Plaintiff: Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant: Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Harmony Biosciences, LLC et al v. AET Pharma US, Inc. et al
as 1:2023cv01340
Plaintiff: Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche and Bioprojet Pharma SAS
Defendant: AET Pharma US, Inc., Annora Pharma Private Limited, Hetero USA, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?